Medicare’s coverage for absorbent incontinence supplies is limited. You may be eligible for coverage under Part C, but most plans focus on DME, outpatient treatments, and prescription medications.

Leading Edge Innovations owns the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male incontinence device. Avalon owns a 40% interest in LSM.

They're both featured on a list of 30 innovations that could save millions of lives over the next 15 years.

They're both featured on a list of 30 innovations that could save millions of lives over the next 15 years.

Leading Edge Innovations owns the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male incontinence device. Avalon owns a 40% interest in LSM.

They're both featured on a list of 30 innovations that could save millions of lives over the next 15 years.